These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29928924)

  • 1. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
    Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
    J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
    Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps.
    Sher MR; Steven GC; Romett JL; Pien G; LeBenger K; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Rhinology; 2020 Feb; 58(1):25-35. PubMed ID: 31815255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.
    Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK
    Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
    Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
    Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis?
    Kovacs AJ; Goshtasbi K; Kuan EC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Fluticasone Exhalation Delivery System in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Wu D; Huang T; Wei Y
    Am J Rhinol Allergy; 2022 Mar; 36(2):176-184. PubMed ID: 34342516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
    Kovacs AJ; Adappa ND; Kuan EC
    Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different types of intranasal steroids for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays.
    Senior BA; Schlosser RJ; Bosso J; Soler ZM
    Int Forum Allergy Rhinol; 2021 May; 11(5):837-845. PubMed ID: 32970395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps.
    Ow RA; McGinnis JP; Sacks HJ; Mehle ME
    Ear Nose Throat J; 2022 Apr; ():1455613221088698. PubMed ID: 35437059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the ocular safety associated with the exhalation delivery system with fluticasone.
    Skoner DP; Meltzer EO; Skoner J; Sacks HJ; Lumry WR
    Allergy Asthma Proc; 2022 Jan; 43(1):70-77. PubMed ID: 34753535
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.
    Aukema AA; Mulder PG; Fokkens WJ
    J Allergy Clin Immunol; 2005 May; 115(5):1017-23. PubMed ID: 15867860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis.
    Palmer JN; Jacobson KW; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
    Int Forum Allergy Rhinol; 2018 Jun; 8(8):869-76. PubMed ID: 29856520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Dexamethasone Versus Fluticasone Nasal Sprays in Postoperative Patients With Chronic Rhinosinusitis With Nasal Polyps.
    Seiberling KA; Kidd SC; Kim GH; Church CA
    Am J Rhinol Allergy; 2019 Sep; 33(5):478-482. PubMed ID: 30987428
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 microg once daily and twice daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients.
    Penttilä M; Poulsen P; Hollingworth K; Holmström M
    Clin Exp Allergy; 2000 Jan; 30(1):94-102. PubMed ID: 10606936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
    Soler ZM; Colman S; Velez FF; Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):848-855. PubMed ID: 32445277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.